Cns Lymphoma clinical trials

Explore recruiting cns lymphoma clinical trials.

Recruiting cns lymphoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cns Lymphoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Pilot-trial of methotrexate, tafasitamab (Minjuvi®), lenalidomide (Revlimid®) and rituximab in patients ineligible for HCT-ASCT with primary central nervous system lymphoma (PCNSL) -MTR²

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Evaluation of the safety and efficacy of Berubicin in the treatment of central nervous system lymphomas- BERUBICIN

Poland

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Optimizing MATRix as remission induction in PCNSL: De-escalated induction treatment in newly diagnosed primary CNS lymphoma – a randomized phase III trial

Austria, Italy, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Dose dense re-challenge of high dose methotrexate (hd-mtx) with glucarpidase (cpg2) for relapsed primary cns lymphoma (pcnsl): A phase 1 trial (METHOGLU)

France

Human Pharmacology (Phase I)- Other EU CTIS Study details

[18F]-Fludarabine PET/MR Imaging for the Assessment of Newly-diagnosed Primary Central Nervous System (CNS) Lymphoma : a Pilot PET-MRI Study

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – a randomized phase III trial - PRIMA-CNS

Germany, Austria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Cns Lymphoma trials by city

Cns Lymphoma in Toronto Cns Lymphoma in Vancouver Cns Lymphoma in Montreal Cns Lymphoma in Calgary Cns Lymphoma in Edmonton Cns Lymphoma in Ottawa Cns Lymphoma in Winnipeg Cns Lymphoma in Quebec City Cns Lymphoma in Hamilton Cns Lymphoma in Kitchener Cns Lymphoma in London Cns Lymphoma in Halifax Cns Lymphoma in New York Cns Lymphoma in Los Angeles Cns Lymphoma in Chicago Cns Lymphoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease